
The Production Linked Incentive programme has emerged as a key policy tool to strengthen domestic manufacturing, scale up exports and improve employment outcomes across priority sectors.
As per the latest update shared in Parliament, the scheme has delivered measurable gains in investment, output and capacity creation, even amid a challenging global trade environment.
As of September 2025, actual investments of about ₹2 lakh crore have been realised across 14 approved PLI sectors. These investments have resulted in incremental production and sales of more than ₹18.7 lakh crore and employment generation exceeding 12.6 lakh jobs, including both direct and indirect roles.
The government noted that the impact has been particularly visible in sectors such as pharmaceuticals, medical devices, electronics, telecom equipment and white goods.
Under the PLI scheme for medical devices, 21 projects have commenced manufacturing of 54 distinct products, including high end equipment such as linear accelerators, MRI and CT scanners, heart valves, stents, dialyser machines, cath labs and mammographs.
In pharmaceuticals, India has strengthened domestic capacity in critical bulk drugs such as Penicillin G, reduced import dependence and consolidated its position as the world’s third largest producer by volume, with exports accounting for about 50% of output.
Domestic mobile phone production rose sharply from ₹18,000 crore in FY15 to ₹5.45 lakh crore in FY25, reflecting a nearly 28 fold increase. The telecom sector has achieved import substitution of around 60%, with India becoming largely self reliant in antennae, GPON and customer premises equipment.
Global technology firms have also established manufacturing bases in the country, turning India into a significant exporter of 4G and 5G telecom equipment.
In the white goods segment, 84 companies approved under the PLI scheme for air conditioners and LED lights are expected to invest ₹10,478 crore, strengthening domestic manufacturing depth.
Cumulative incentives of ₹23,946 crore have been disbursed as of 30 September 2025 across 12 sectors, including large scale electronics, IT hardware, bulk drugs, medical devices, pharmaceuticals, telecom products, food processing, white goods, drones, specialty steel, textiles and automobiles.
Read More: Nearly ₹2,000 Crore Returned Under ‘Your Money, Your Right’ Initiative!
The PLI programme has delivered tangible gains in manufacturing scale, employment and export competitiveness, while complementary trade and MSME initiatives aim to sustain momentum and deepen India’s integration into global value chains.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.
Published on: Dec 13, 2025, 10:36 AM IST

Team Angel One
We're Live on WhatsApp! Join our channel for market insights & updates